Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity of Japanese Encephalitis Vaccine IC51 Commercial Batch up to 24 Months Post Filling
2008-004634-24Phase 3Completed
- Sponsor
- Intercell AG
- Start
- Jul 2008
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, open-label trial of japanese encephalitis vaccine (inactivated, adsorbed) in Japanese encephalitis (JE) (3 arms), sponsored by Intercell AG. Started Jul 2008; status: completed.
02
Drugs
japanese encephalitis vaccine (inactivated, adsorbed)
03
Conditions
Japanese encephalitis (JE)
Beyond the preview
Go deeper on 2008-004634-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004634-24.